Posttreatment Lyme Disease Syndrome

Research output: Contribution to journalReview articlepeer-review

Abstract

The prognosis following appropriate antibiotic treatment of early or late Lyme disease is favorable but can be complicated by persistent symptoms of unknown cause termed posttreatment Lyme disease syndrome (PTLDS), characterized by fatigue, musculoskeletal pain, and cognitive complaints that persist for 6months or longer after completion of antibiotic therapy. Risk factors include delayed diagnosis, increased severity of symptoms, and presence of neurologic symptoms at time of initial treatment. Two-tier serologic testing is neither sensitive nor specific for diagnosis of PTLDS because of variability in convalescent serologic responses after treatment of early Lyme disease. Optimal treatment of PTLDS awaits more precise understanding of the pathophysiologic mechanisms involved in this illness and future treatment trials.

Original languageEnglish (US)
Pages (from-to)309-323
Number of pages15
JournalInfectious disease clinics of North America
Volume29
Issue number2
DOIs
StatePublished - Jun 1 2015

Keywords

  • Fatigue
  • Fibromyalgia
  • Musculoskeletal pain
  • Persistent symptoms
  • Posttreatment Lyme disease syndrome

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Posttreatment Lyme Disease Syndrome'. Together they form a unique fingerprint.

Cite this